Avanafil is a PDE5 inhibitor approved for erectile dysfunction by the FDA on April 27, 2012 and by EMA on June 21, 2013. Avanafil is sold under the brand names Stendra and Spedra.
Molar mass: 483.96 gmol1
ATC code: G04BE10 (WHO)
License data: EU EMA: by INN; US Daily Med: Avanafil; US FDA: Avanafil